Case 446 · ICHD-3 7.1.2
7.1.2 Headache attributed to intracranial hypertension secondary to metabolic, toxic or hormonal cause
- Origin
- Synthetic
- Language
- English — also available in German
- Contributed by
- Imported case — HeadAI synthetic vignettes (de Andrade JBC, da Silva Costa TB, Vasconcelos JL, Lopes TLM, Balsells MD, Cristofolini VL, Querobin SO, Filho FMR. Validation of an AI-based platform for structured diagnosis of headache disorders using ICHD-3 criteria. BMC Neurology 25, 489 (2025). doi:10.1186/s12883-025-04473-1. Dataset: Andrade J. Head.AI Platform. Mendeley Data, V2 (2025). doi:10.17632/4fms6cw2s5.2)
Anamnesis
Identification: Sex/Age: Female, 19 years
History: History of severe acne treated with oral isotretinoin (40 mg/day) for 3 months
Current medication: Isotretinoin 40 mg/day + vitamin A supplement 25,000 IU/day (self-medication)
Family history: Maternal migraine
History of Present Illness (HPI): Main symptom: Daily headache for 2 weeks
Characteristics:
Location: Holocranial
Character: Constant pressure
Intensity: 6-7/10
Aggravation: Morning and when lying down
Improvement: Orthostatic position
Associated symptoms:
Transient photopsias
Nausea without vomiting
Intermittent horizontal diplopia
Relevant factor: Concomitant use of isotretinoin and megadose of vitamin A
Physical/Neurological Examination: General: Dry skin with cheilitis (side effect of isotretinoin)
Neurological:
Bilateral papilledema (Frisen grade II)
Incomplete paralysis of the right sixth cranial nerve
Remaining examination normal
Meningeal signs: Absent
Complementary Exams: Cranial MRI + venography: No structural changes or venous thrombosis
Lumbar puncture:
ICP = 30 cmH₂O
Clear cerebrospinal fluid, no cytochemical changes
Laboratory:
Serum vitamin A levels: 120 μg/dL (normal values 30-65)
Normal liver and renal function
Report this case — e.g. suspected re-identification risk.